Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection

JAMA

Volumn 284, Issue 2, 2000, Pages 190-197

  de Martino, Maurizio ^a   Tovo, Pier Angelo ^b   Balducci, Maria ^c   Galli, Luisa ^a   Gabiano, Clara ^b   Rezza, Giovanni ^c   Pezzotti, Patrizio ^c   Osimani, Patrizia ^d   Di Bari, Cesare ^d   Larovere, Domenico ^d   Ruggeri, Maurizio ^d   Masi, Massimo ^d   Specchia, Fernando ^d   Battisti, Laura ^d   Duse, Marzia ^d   Crispino, Paola ^d   Carrara, Paolo ^d   Pintor, Carlo ^d   Dedoni, Maurizio ^d   Dessì, Carlo ^d   Loriano, Daniela ^d   Anastasio, Elisa ^d   Bezzi, Teresa ^d   De Luca, Marco ^d   Farina, Silvia ^d   Vierucci, Alberto ^d   Bassetti, Dante ^d   Pontali, Emanuele ^d   Boni, Silvia ^d   Marazzi, Maria Grazia ^d   Tasso, Loredana ^d   Giovanettoni, Chiara ^d   Salvini, Filippo ^d   Pinzani, Raffaella ^d   Marchisio, Paola ^d   Viganò, Alessandra ^d   Tornaghi, Raffaella ^d   Zuccotti, Gian Vincenzo ^d   Riva, Enrica ^d   Giovannini, Marcello ^d   Lipreri, Rita ^d   Conio, Stefania ^d   Ferraris, Gabriele ^d   Cellini, Monica ^d   Baraldi, Cecilia ^d   Guarino, Alfredo ^d   Canani, Roberto Berni ^d   Tarallo, Luigi ^d   Giaquinto, Carlo ^d   Ruga, Ezia ^d   Rampon, Osvalda ^d   Nogare, Ernesto Renato Dalle ^d   Sanfilippo, Adriana ^d   Romano, Amelia ^d   Benaglia, Giorgio ^d   Dodi, Icilio ^d   Caselli, Desirèe ^d   Maccabruni, Anna ^d   Pacati, Ilaria ^d   Consolini, Rita ^d   Palla, Gabriella ^d   Cecchi, Maria Teresa ^d   Vecchi, Vico ^d   Anzidei, Gianfranco ^d   Cerilli, Stefano ^d   Chiodi, Rosa ^d   Gattinara, Guido Castelli ^d   Krzysztofiak, Andrea ^d   Bernardi, Stefania ^d   Fundarò, Carlo ^d   Genovese, Orazio ^d   Colafati, Giovanna Stefania ^d   Catania, Salvatore ^d   Ajassa, Camilla ^d   Mazza, Antonio ^d   Garetto, Sara ^d   Riva, Caterina ^d   Scolfaro, Carlo ^d   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PERINATAL INFECTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034641328     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.2.190     Document Type: Article

References (39)

1. Delta Coordinating Committee. Delta: a randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet. 1996;348:283-291.
2. Hammer N, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 220 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
3. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland. BMJ. 1997;315:1194-1199.
4. Detels R, Muñoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280:1497-1503.
5. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
6. Pezzotti P, Napoli PA, Acciai S, et al. Increasing survival time after AIDS in Italy. AIDS. 1999;13:249-255.
7. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet. 1998;352:1725-1730.
8. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS. 1999;13:1933-1942.
9. Porta P, Rapiti E, Forastiere F, et al. Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998. AIDS. 1999;13:2125-2131.
10. Beck EJ, Mandalia S, Williams I, et al. Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of antiretroviral therapy 1996-1997. AIDS. 1999;13:2157-2164.
11. Englund JA, Baker CJ, Raskino C, et al. Zidovudine, didanosine, or both as the initial treatment for symtomatic HIV-infected children. N Engl J Med. 1997; 336:1704-1712.
12. Paediatric European Network for Treatment of AIDS. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children. AIDS. 1998;12:F151-F160.
13. Kline MW, Van Dyke RB, Lindsey JC, et al. Combination therapy with stavudine (d4T) plus didanosine (ddl) in children with human immunodeficiency virus infection. Pediatrics. 1999;103:62-69.
14. Burns DN, Mofenson LM. Paediatric HIV-1 infection. Lancet. 1999;354(suppl2):S1-S6.
15. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet. 1988;2:1043-1045.
16. de Martino M, Tovo P-A, Galli L, et al. Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. J Pediatr. 1991;119:702-709.
17. Tovo P-A, de Martino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet. 1992;339:1249-1253.
18. Gabiano C, Tovo P-A, Tozzi AE, et al. Mother-to-child HIV-1 transmission. Pediatrics. 1992;90:369-374.
19. de Martino M, Tovo P-A, Tozzi AE, et al. HIV-1 transmission through breast-milk. AIDS. 1992;6:991-997.
20. de Martino M, Tovo P-A. Quantifying the risk of HIV-1 transmission via breast-milk. AIDS. 1993;7: 134-135.
21. Italian Register for HIV Infection in Children. Epidemiology of HIV infection in children in Italy. Acta Paediatr Suppl. 1994;400:15-18.
22. de Martino M, Tovo P-A, Galli L, et al. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet. 1994;343:191-195.
23. Galli L, de Martino M, Tovo P-A, et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS. 1995;9:455-461.
24. Tovo P-A, de Martino M, Gabiano C, et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:88-94.
25. Italian Register for HIV Infection in Children. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. AIDS. 1999;13:927-933.
26. Italian Register for HIV Infection in Children. Italian guidelines for antiretroviral therapy in children with HIV-1 infection. Acta Paediatr. 1999;88:228-232.
27. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep. 1994;43 (RR-12):1-10.
28. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1-17.
29. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep. 1998;47 (RR-4):1-43.
30. Kuhn L, Steker RW, Weedon J, et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. J Infect Dis. 1999;179:52-58.
31. Clayton C, Hills M. Statistical Models in Epidemiology. Oxford, England: Oxford University Press; 1993.
32. Muñoz A, Hoover DR. Use of cohort studies for evaluating AIDS therapies. In: Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. New York, NY: John Wiley & Sons Inc; 1995:423-446.
33. Blanche S, Mayaux M-J, Rouzioux C, et al. Relation of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med. 1994;330:308-312.
34. Sabin CA. Assessing the impact of highly active antiretroviral therapy on AIDS and death. AIDS. 1999; 13:2165-2166.
35. Shearer WT, Guinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med. 1997;336:1337-1342.
36. Krogsted P, Uittenbogaart CH, Dickover R, et al. Primary HIV infection in infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol. 1999;92:25-33.
37. Sharland M, Watkins AM, Dalgleish AG, et al. Immune reconstitution in HAART-treated children with AIDS. Lancet. 1998;352:577-578.
38. Cohen Stuart JW, Slieker WA, Rijkers GT, et al. Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. AIDS. 1998;12: 2155-2159.
39. Haynes BF. HIV infection and the dynamic interplay between the thymus and the peripheral T cell pool. Clin Immunol. 1999;92:3-5.